Clinical Trials Browser

Phase 1/2 × Unknown × trifluridine tipiracil drug combination × Clear all

NCT06379399 2024-04-23

Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

Phase 1/2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic